First-trimester sex hormone binding globulin and subsequent gestational diabetes mellitus

American Journal of Obstetrics and Gynecology

Volumn 189, Issue 1, 2003, Pages 171-176

  Thadhani, Ravi ^a   Wolf, Myles ^a   Hsu Blatman, Karen ^a   Sandler, Laura ^a   Nathan, David ^a   Ecker, Jeffrey L ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Gestational diabetes mellitus; Insulin resistance; Sex hormone binding globulin

Indexed keywords

BIOCHEMICAL MARKER; ESTRADIOL; SEX HORMONE BINDING GLOBULIN; TESTOSTERONE;

ADULT; ARTICLE; BLOOD SAMPLING; BODY MASS; CASE CONTROL STUDY; CESAREAN SECTION; CLINICAL ARTICLE; FEMALE; FIRST TRIMESTER PREGNANCY; GLUCOSE BLOOD LEVEL; HIGH RISK PREGNANCY; HUMAN; INSULIN RESISTANCE; LIFESTYLE; LOGISTIC REGRESSION ANALYSIS; MACROSOMIA; NEWBORN MORBIDITY; PREGNANCY DIABETES MELLITUS; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; SCREENING;

EID: 0038675041     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1067/mob.2003.343     Document Type: Article

References (35)

1. Tuomilehto J, Lindstrom J, Eriksson JG, Valle TT, Hamalainen H, Ilanne-Parikka P, et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 2001;344:1343-50.
2. King H. Epidemiology of glucose intolerance and gestational diabetes in women of childbearing age. Diabetes Care 1998;21(Suppl):B9-13.
3. Casey BM, Lucas MJ, McIntire DD, Leveno KJ. Pregnancy outcomes in women with gestational diabetes compared with the general obstetric population. Obstet Gynecol 1997;90:869-73.
4. American College of Obstetricians and Gynecologists. Gestational diabetes. Washington (DC): The College; 2001. Practice bulletin No.: 30.
5. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 2001;24(Suppl):S5-20.
6. Solomon CG, Hu FB, Dunaif A, Rich-Edwards J, Willett WC, Hunter DJ, et al. A prospective study of pregravid determinants of gestational diabetes mellitus. JAMA 1997;278:1078-83.
7. Coustan DR, Nelson C, Carpenter MW, Carr SR, Rotondo L, Widness JA. Maternal age and screening for gestational diabetes: a population-based study. Obstet Gynecol 1989;73:557-61.
8. Haffner SM, Katz MS, Stern MP, Dunn JF. The relationship of sex hormones to hyperinsulinemia and hyperglycemia. Metabolism 1988;37:683-8.
9. Haffner SM, Valdez RA, Morales PA, Hazuda HP, Stern MP. Decreased sex hormone-binding globulin predicts noninsulin-dependent diabetes mellitus in women but not in men. J Clin Endocrinol Metab 1993;77:56-60.
10. Lindstedt G, Lundberg PA, Lapidus L, Lundgren H, Bengtsson C, Bjorntorp P. Low sex-hormone-binding globulin concentration as independent risk factor for development of NIDDM: 12-yr follow-up of population study of women in Gothenburg, Sweden. Diabetes 1991;40:123-8.
11. Sherif K, Kushner H, Falkner BE. Sex hormone-binding globulin and insulin resistance in African-American women. Metabolism 1998;47:70-4.
12. Bartha JL, Comino-Delgado R, Romero-Carmona R, Gomez-Jaen MC. Sex hormone-binding globulin in gestational diabetes. Acta Obstet Gynecol Scand 2000;79:839-45.
13. Wolf M, Sandler L, Munoz K, Hsu K, Ecker JL, Thadhani R. First trimester insulin resistance and subsequent preeclampsia: a prospective study. J Clin Endocrinol Metab 2002;87:1563-8.
14. Hampl R, Starka L. Sex hormone-binding globulin in endocrine regulation [minireview]. Endocr Regul 1996;30:57-65.
15. Key TJ, Pike MC, Moore JW, Wang DY, Morgan B. The relationship of free fatty acids with the binding of oestradiol to SHBG and to albumin in women. J Steroid Biochem 1990;35:35-8.
16. Loukovaara M, Carson M, Adlercreutz H. Regulation of production and secretion of sex hormone-binding globulin in HepG2 cell cultures by hormones and growth factors. J Clin Endocrinol Metab 1995;80:160-4.
17. Anderson DC. Sex-hormone-binding globulin. Clin Endocrinol (Oxf) 1974;3:69-96.
18. Pasquali R, Vicennati V, Bertazzo D, Casimirri F, Pascal G, Tortelli O, et al. Determinants of sex hormone-binding globulin blood concentrations in premenopausal and postmenopausal women with different estrogen status: Virgilio-Menopause-Health Group. Metabolism 1997;46:5-9.
19. Krotkiewski M, Holm G, Shono N. Small doses of triiodothyronine can change some risk factors associated with abdominal obesity. Int J Obes Relat Metab Disord 1997;21:922-9.
20. Plymate SR, Matej LA, Jones RE, Friedl KE. Inhibition of sex hormone-binding globulin production in the human hepatoma (Hep G2) cell line by insulin and prolactin. J Clin Endocrinol Metab 1988;67:460-4.
21. Goodman-Gruen D, Barrett-Connor E. Sex hormone-binding globulin and glucose tolerance in postmenopausal women: the Rancho Bernardo Study. Diabetes Care 1997;90:645-9.
22. Buchanan TA. Pancreatic B-cell defects in gestational diabetes: implications for the pathogenesis and prevention of type 2 diabetes. J Clin Endocrinol Metab 2001;86:989-93.
23. Crave JC, Fimbel S, Lejeune H, Cugnardey N, Dechaud H, Pugeat M. Effects of diet and metformin administration on sex hormone-binding globulin, androgens, and insulin in hirsute and obese women. J Clin Endocrinol Metab 1995;80:2057-62.
24. Velazquez EM, Mendoza S, Hamer T, Sosa F, Glueck CJ. Metformin therapy in polycystic ovary syndrome reduces hyperinsulinemia, insulin resistance, hyperandrogenemia, and systolic blood pressure, while facilitating normal menses and pregnancy. Metabolism 1994;43:647-54.
25. Hamilton-Fairley D, White D, Griffiths M, Anyaoku V, Koistinen R, Seppala M, et al. Diurnal variation of sex hormone binding globulin and insulin-like growth factor binding protein-1 in women with polycystic ovary syndrome. Clin Endocrinol (Oxf) 1995;43:159-65.
26. Tallarigo L, Giampietro O, Penno G, Miccoli R, Gregori G, Navalesi R. Relation of glucose tolerance to complications of pregnancy in nondiabetic women. N Engl J Med 1986;315:989-92.
27. Sermer M, Naylor CD, Farine D, Kenshole AB, Ritchie JW, Gare DJ, et al. The Toronto Tri-Hospital Gestational Diabetes Project: a preliminary review. Diabetes Care 1998;21(Suppl):B33-42.
28. Garner P, Okun N, Keely E, Wells G, Perkins S, Sylvain J, et al. A randomized controlled trial of strict glycemic control and tertiary level obstetric care versus routine obstetric care in the management of gestational diabetes: a pilot study. Am J Obstet Gynecol 1997;177:190-5.
29. Li DF, Wong VC, O'Hoy KM, Yeung CY, Ma HK. Is treatment needed for mild impairment of glucose tolerance in pregnancy? A randomized controlled trial. Br J Obstet Gynaecol 1987;94:851-4.
30. Persson B, Stangenberg M, Hansson U, Nordlander E. Gestational diabetes mellitus (GDM): comparative evaluation of two treatment regimens, diet versus insulin and diet. Diabetes 1985;34(Suppl):101-5.
31. Thompson DJ, Porter KB, Gunnells DJ, Wagner PC, Spinnato JA. Prophylactic insulin in the management of gestational diabetes. Obstet Gynecol 1990;75:960-4.
32. Langer O, Rodriguez DA, Xenakis EM, McFarland MB, Berkus MD, Arrendondo F. Intensified versus conventional management of gestational diabetes. Am J Obstet Gynecol 1994;170:1036-46.
33. de Veciana M, Major CA, Morgan MA, Asrat T, Toohey JS, Lien JM, et al. Postprandial versus preprandial blood glucose monitoring in women with gestational diabetes mellitus requiring insulin therapy. N Engl J Med 1995;333:1237-41.
34. Canadian Task Force on the Periodic Health Examination. Screening for gestational diabetes mellims. CMAJ 1992;147:435-43.
35. US Preventive Services Task Force. Screening for diabetes mellitus. In: Guide to clinical preventive services. 2nd ed. Washington (DC): Office of Disease Prevention and Health Promotion, US Government Printing Office; 1996. p. 193-208.